Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss	$ (8,635,592)	$ (7,240,686)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Depreciation	3,292,788	3,118,402
Amortization of debt issuance costs	159,852	367,285
Stock based compensation expense related to issuance of restricted stock	10,873	10,977
Equity in loss of unconsolidated real estate ventures	813,829	222,528
Unrealized derivative gain	377,141	158,595
Derivative fair value adjustment		410,657
Unrealized foreign currency adjustment	1,730,274	195,936
Changes in operating assets and liabilities:
Other assets, net	(723,741)	(316,417)
Settlement of interest rate derivative		(2,030,731)
Accounts payable and accrued liabilities	689,391	831,030
Due to affiliates	3,544,117	2,978,762
Net cash provided by (used in) operating activities	1,258,932	(1,293,662)
Cash flows from investing activities:
Additions to real estate facilities	(1,345,026)	(3,024,103)
Investments in unconsolidated real estate ventures	(510,697)	(986,166)
Return of capital on investments in unconsolidated real estate ventures	6,367,664
Net cash provided by (used in) investing activities	4,511,941	(4,010,269)
Cash flows from financing activities:
Proceeds from issuance of secured debt	340,390	170,533,452
Repayment of secured debt		(164,535,746)
Scheduled principal payments of secured debt	(652,749)	(655,276)
Debt issuance costs		(1,765,499)
Gross proceeds from issuance of common stock		7,245,023
Offering costs	(170,444)	(805,069)
Proceeds from issuance of Series C units		294,276
Redemption of common stock	(193,867)	(442,933)
Distributions paid to common stockholders	(2,196,856)	(2,047,641)
Distributions paid to noncontrolling interest in our Operating Partnership	(84,089)	(83,930)
Distributions paid to preferred stockholders	(3,156,986)	(3,148,361)
Net cash provided by (used in) financing activities	(6,114,601)	4,588,296
Impact of foreign exchange rate changes on cash and restricted cash	(31,065)	6,710
Net change in cash, cash equivalents and restricted cash	(374,793)	(708,925)
Cash, cash equivalents and restricted cash, beginning of year	9,918,161	17,565,564
Cash, cash equivalents and restricted cash, end of year	9,543,368	16,856,639
Supplemental disclosures and non-cash transactions:
Cash paid for interest, net of amounts capitalized	3,725,190	3,336,189
Offering costs included in accounts payable and accrued liabilities	0	62,904
Other assets in due to affiliates	1,242,722
Interest rate swap contract in other assets	156,554	790,781
Interest rate swap contracts in accounts payable and accrued liabilities	222,015	592,916
Foreign currency hedge contract in other assets		155,256
Foreign currency translation adjustment	(674,141)	63,949
Issuance of shares pursuant to distribution reinvestment plan	1,653,126	1,600,498
Distributions payable to common and preferred stockholders	5,114,510	4,360,414
Distributions payable to noncontrolling interests in our Operating Partnership	28,964	28,964
Real estate and construction in process in accounts payable and accrued liabilities	1,029,992	714,142
Redemption of common stock in accounts payable and accrued liabilities	95,000	$ 174,377
Purchase of interest rate derivative in accounts payable and accrued liabilities	$ 1,122,401